[1] |
LIU Biqing, ZHANG Xiaotong, WANG Ke, XING Xiaoxuan, WANG Zhizhou, ZHUANG Wei, ZHANG Qingxia, ZHANG Lan, LI Xiaoling, DONG Xianzhe.
Adverse Drug Reaction in 385 Elderly Inpatients with Bacterial Pneumonia under Polypharmacy
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(2): 206-210.
|
[2] |
ZHU Yuanchao, ZHANG Yatong, HU Xin.
Principles and measures of medication risk management in the elderly
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(9): 1031-1034.
|
[3] |
ZHU Yuanchao, ZHAO Ming, HU Xin, SHI Hong.
Pharmacist-led practice in the management of elderly patients with polypharmacy
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 817-821.
|
[4] |
HUO Peiqiong, ZHENG Peng, SU Zhenhao.
Pharmacovigilance in retail pharmacies for special or major diseases
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(4): 428-432.
|
[5] |
LIU Hongliang, WANG Qing, HOU Yongfang.
Design and implementation of polypharmacy risk data management platform for common diseases of the elderly based on real world data
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(10): 1095-1098.
|
[6] |
LIU Bin, SHAO Meiling, CAI Yiran, MA Fengyi, LAN Hong.
Applicability of PDCA cycle in standardization of outpatient prescriptions
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(9): 1035-1039.
|
[7] |
ZHAO Xuan, GUO Jing, MEI Long, ZHANG Wei.
Automatic dispensing system on influence of work efficiency of outpatient pharmacy and the safety of prevention and control of COVID-19
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(5): 564-567.
|
[8] |
CAI Lele, ZHANG Zhuolin, LI Xin, FANG Danjun, HAN Feng.
Research progress in safety and effectiveness of medication of iron deficiency anemia
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(11): 1262-1265.
|
[9] |
ZHAO Xuan, GUO Jing, REN Shuang, ZHEN Jiancun.
Management and working modes of outpatient pharmacies amid routine COVID-19 epidemic prevention
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(1): 100-102.
|
[10] |
GENG Hongjiao, WANG Lianxin, XIE Yanming.
Pharmacovigilance of Chinese Medicine in Medical Institutions
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(6): 552-555.
|
[11] |
ZHANG Yongna, ZHANG Yanjiao, ZHAO Li, HAN Yongxin.
One Case of Drug Treatment and Pharmaceutical Care in Patients with HIT after Coronary Artery Bypass Grafting
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(3): 284-288.
|
[12] |
DONG Min, ZOU Tong, XU Lei, HE Qinghua, PEI Zuowei, WANG Fang.
Effects of Polypharmacy on Long-term Prognosis of Elderly Patients with Coronary Heart Disease and Atrial Fibrillation
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(2): 126-132.
|
[13] |
YANG Juanyan, YANG Fangrong, YANG Shuang, DAI Jiansong, YANG Ling, BAO Gang.
Application of QCC in Improving Monitoring of ADR Reports in a Hospital
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(7): 412-417.
|
[14] |
BAI Shunmin, FAN Zhe.
Improper Prescriptions for Antitumor Drugs in Pharmacy Intravenous Admixture Services
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(4): 239-244.
|
[15] |
LIU Jian, LI Yonghui, LU Ming, ZHANG Yuan.
Analysis of Irrational Medical Advices in Pharmacy Intravenous Admixture Service in A Hospital
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(10): 735-739.
|